Logo-jre
Submitted: 05 Sep 2022
Accepted: 02 Oct 2022
ePublished: 08 Oct 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Endocrinol. 2022;8: e21064.
doi: 10.34172/jre.2022.21064
  Abstract View: 63
  PDF Download: 45

Review

Metformin and kidney; overview on current concepts

Hamid Nasri* ORCID logo

1 Nickan Research Institute, Isfahan, Iran.
*Corresponding Author: Corresponding Author: Prof. Hamid Nasri, Email: hamidnasri@yahoo.com, , Email: hamidnasri@med.mui.ac.ir

Abstract

Type 2 diabetes (T2DM) is a chronic disorder categorized by hyperglycemia due to insulin resistance of cells. T2DM can cause many micro or macrovascular complications. Metformin, a biguanides derivative, has multiple benefits except anti-hyperglycemia effect, comprising amelioration blood cholesterol levels, blood pressure and depressing vascular complications accompanied with T2DM. It is proposed that metformin act via adenosine monophosphate-activated protein kinase (AMPK) -dependent or -independent approaches. The mechanisms by which metformin regulates glycemic level in T2DM are complex. In addition to its peripheral effects on insulin resistance and glycogenesis, metformin has direct beneficial effect on the beta-cell secretion. A large part of the metabolic advantages of metformin can be related to effects on gastrointestinal glucose uptake and the interaction of metformin with numerous new objects for glucose depressing in the gastrointestinal tract, including the incretin receptors, bile salt transporters and the gut microbiota.

Citation: Nasri H. Metformin and kidney; overview on current concepts. J Ren Endocrinol. 2022;8:e21064. doi: 10.34172/jre.2022.21064.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 64

Your browser does not support the canvas element.


PDF Download: 45

Your browser does not support the canvas element.